Susquehanna International Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$401K Sell
1,216,000
-1,754,700
-59% -$2.76M ﹤0.01% 10206
2025
Q4
$9.21M Sell
2,970,700
-330,900
-10% -$944K ﹤0.01% 3150
2025
Q3
$8.68M Buy
3,301,600
+2,075,900
+169% +$4.58M ﹤0.01% 3223
2025
Q2
$1.51M Buy
1,225,700
+255,200
+26% +$278K ﹤0.01% 6431
2025
Q1
$1.07M Buy
970,500
+799,500
+468% +$924K ﹤0.01% 7100
2024
Q4
$154K Buy
171,000
+106,900
+167% +$91.6K ﹤0.01% 10993
2024
Q3
$63.5K Sell
64,100
-33,300
-34% -$32K ﹤0.01% 11286
2024
Q2
$87.7K Sell
97,400
-1,300
-1% -$973 ﹤0.01% 11110
2024
Q1
$116K Buy
98,700
+32,300
+49% +$35.6K ﹤0.01% 11113
2023
Q4
$60.4K Sell
66,400
-56,600
-46% -$41.8K ﹤0.01% 11636
2023
Q3
$102K Buy
123,000
+109,800
+832% +$127K ﹤0.01% 10902
2023
Q2
$15.8K Sell
13,200
-133,900
-91% -$167K ﹤0.01% 11683
2023
Q1
$185K Buy
147,100
+88,800
+152% +$170K ﹤0.01% 10693
2022
Q4
$127K Sell
58,300
-243,000
-81% -$2M ﹤0.01% 10707
2022
Q3
$3.61M Sell
301,300
-49,800
-14% -$618K ﹤0.01% 3721
2022
Q2
$2.94M Sell
351,100
-31,500
-8% -$244K ﹤0.01% 4115
2022
Q1
$3.32M Buy
382,600
+350,500
+1,092% +$3.38M ﹤0.01% 4427
2021
Q4
$363K Sell
32,100
-46,200
-59% -$549K ﹤0.01% 10022
2021
Q3
$984K Buy
78,300
+53,600
+217% +$493K ﹤0.01% 7593
2021
Q2
$201K Sell
24,700
-16,800
-40% -$146K ﹤0.01% 11590
2021
Q1
$384K Buy
41,500
+5,800
+16% +$58.5K ﹤0.01% 10074
2020
Q4
$345K Buy
35,700
+5,100
+17% +$50.2K ﹤0.01% 8994
2020
Q3
$380K Sell
30,600
-5,700
-16% -$75.6K ﹤0.01% 8240
2020
Q2
$472K Buy
+36,300
New +$457K ﹤0.01% 7479
2019
Q4
Sell
-14,000
Closed -$235K 10035
2019
Q3
$235K Buy
+14,000
New +$278K ﹤0.01% 8791

Other funds holding GOSS

Susquehanna International Group's GOSS Position: Q1 2026 in Review

Susquehanna International Group increased its Gossamer Bio (GOSS) stake by 53% in Q1 2026, buying an estimated $74.4K and bringing the position to 135,773 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #12665.

Susquehanna International Group first reported a position in GOSS in Q3 2019 and has held it in 23 quarters since. The position peaked at $3.21M in Q1 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Susquehanna International Group held 135,773 shares of Gossamer Bio worth $44.6K as of Q1 2026.
  • Susquehanna International Group bought 47,318 Gossamer Bio shares in Q1 2026, an estimated $74.4K.
  • Gossamer Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12665 holding.
  • Susquehanna International Group first reported a position in Gossamer Bio in Q3 2019 and has held it in 23 quarters since.
  • Susquehanna International Group's Gossamer Bio position peaked at $3.21M in Q1 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.